Abstract
The indication to apply nephrocutaneous bypass should primarily cover patients with malignant ureteral obstruction, a life expectancy of <12 months, and reduced general conditions. In particular clinical circumstances, this method may be a useful alternative also for long-term urinary diversion in patients with a less reduced life expectancy, including etiologically nonmalignant ureteric obstruction or lost/severely impaired ureteric functionality. Several reports cover this benign subgroup of thoroughly selected patients, and the respective indications include aortic aneurysm, retroperitoneal fibrosis, and ureteral necrosis after kidney transplantation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
